← Leaderboards
Colin Henry Beckwitt
University Of Pittsburgh At Pittsburgh
$142,144
Attributed
$142,144
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2016–18$50K$37.5K$25K$12.5K$0
'16
'17
'18
Funding mix
By agency
NIH$142,144 · 1
By mechanism
F30$142,144 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Shivendra Singh$26,555,479
- Candace S Johnson$18,922,226
- Jeremy N Rich$24,023,429
- Kathryn H. Schmitz$25,381,755
- Mark T. Miedel$2,142,086
Others in their field
Top investigators on “Adjuvant Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$265,384,749
- Norman Wolmark · Nsabp Foundation, Inc.$252,082,455
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$105,968,129
- David Heimbrook · Leidos Biomedical Research, Inc.$59,661,099
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
Adjuvant TherapyAdjuvant ChemotherapyAffectAntitumor AgentBaseAdvanced Malignant NeoplasmBlood CirculationBreast Cancer Cell LineCancer CellCancer TypeCareer DevelopmentCell Culture TechniquesBiosensorCell DivisionCell ProliferationCellsCell TypeCellular Metabolic ProcessCessation Of LifeChemosensitizationChemotherapeutic AgentCisplatinCoculture TechniquesConfounding Factors (Epidemiology)